Ameliora Wealth Management’s Advanced Micro Devices AMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$399K Hold
1,959
0.13% 77
2025
Q4
$420K Buy
1,959
+109
+6% +$24.5K 0.13% 77
2025
Q3
$299K Buy
1,850
+90
+5% +$14.5K 0.1% 90
2025
Q2
$250K Sell
1,760
-665
-27% -$72.4K 0.09% 92
2025
Q1
$249K Sell
2,425
-4,854
-67% -$540K 0.09% 90
2024
Q4
$879K Buy
7,279
+307
+4% +$44.2K 0.33% 45
2024
Q3
$1.14M Buy
6,972
+310
+5% +$47.1K 0.48% 38
2024
Q2
$1.08M Sell
6,662
-97
-1% -$15.6K 0.49% 41
2024
Q1
$1.22M Buy
6,759
+1,550
+30% +$271K 0.55% 44
2023
Q4
$768K Buy
5,209
+231
+5% +$27.2K 0.38% 46
2023
Q3
$512K Hold
4,978
0.3% 50
2023
Q2
$567K Sell
4,978
-320
-6% -$33.3K 0.35% 47
2023
Q1
$519K Buy
5,298
+4,978
+1,556% +$405K 0.3% 61
2022
Q4
$20.7K Hold
320
0.01% 184
2022
Q3
$15K Buy
+320
New +$27.2K 0.01% 186

Other funds holding AMD

Ameliora Wealth Management's AMD Position: Q1 2026 in Review

Ameliora Wealth Management held its Advanced Micro Devices (AMD) position steady in Q1 2026 at 1,959 shares worth $399K. The position accounts for 0.13% of the portfolio, ranked #77.

Ameliora Wealth Management first reported a position in AMD in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.22M in Q1 2024. 3,167 funds tracked by Wall St. Rank hold AMD as of Q1 2026.

  • Ameliora Wealth Management held 1,959 shares of Advanced Micro Devices worth $399K as of Q1 2026.
  • Ameliora Wealth Management left its Advanced Micro Devices share count unchanged in Q1 2026.
  • Advanced Micro Devices made up 0.13% of Ameliora Wealth Management's portfolio in Q1 2026, its #77 holding.
  • Ameliora Wealth Management first reported a position in Advanced Micro Devices in Q3 2022 and has held it in 15 quarters since.
  • Ameliora Wealth Management's Advanced Micro Devices position peaked at $1.22M in Q1 2024.
  • 3,167 funds tracked by Wall St. Rank held Advanced Micro Devices as of Q1 2026.

Based on Ameliora Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.